Hydroflumethiazide

In the US, Hydroflumethiazide is a member of the drug class thiazide diuretics and is used to treat Edema and High Blood Pressure.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C03AA02

CAS registry number (Chemical Abstracts Service)

0000135-09-1

Chemical Formula

C8-H8-F3-N3-O4-S2

Molecular Weight

331

Therapeutic Category

Diuretic agent, benzothiadiazide

Chemical Name

2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide

Foreign Names

• Hydroflumethiazidum (Latin)
• Hydroflumethiazid (German)
• Hydrofluméthiazide (French)
• Hidroflumetiazida (Spanish)

Generic Names

• Hydroflumethiazide (OS: JAN, BAN)
• Hydrofluméthiazide (OS: DCF)
• Idroflumetiazide (OS: DCIT)
• Metforylthiadiazin (IS)
• Hydroflumethiazide (PH: USP 32, BP 2010)
• Hydroflumethiazidum (PH: Ph. Int. 2)

Brand Names

• Aldactide (Hydroflumethiazide and Spironolactone)
  Pfizer, Bahrain; Pfizer, United Kingdom; Pharmacia, Ireland



• Hydroflumethiazide
  Par, United States



• Saluron
  Shire, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.